Mountainfield Venture Partners
Location on request
Check size
🔒 $•• – $••Partners & team
1 contact on file
LinkedIn profile
Sign up free to unlock contact →Mountainfield Venture Partners in the news
citybiz
cAMPfield Therapeutics Launches With $180M Series A
1 month ago
cAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara
1 month ago
New biotech cAMPfield emerges with $180M to reshape IBD treatment
1 month ago
cAMPfield Launches With $180 Million Series A to Advance Prifemilast, a Potential Best-in-Class Oral Therapy for IBD
1 month ago
InnoCare, Keymed sell ex-China rights for bispecific to RTW-built biotech in $520M deal
Jan 2025
Newco Prolium licenses antibody from Innocare, Keymed for $520M
Jan 2025
Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing
Jan 2025
Biotech creator and China's Keymed launch antibody company with $180M series A
Jan 2025
Timberlyne Therapeutics Launches with a $180 Million Series A Financing to Advance CM313, a Potentially Best-in-Class Anti-CD38 Monoclonal Antibody, for Diseases of High Unmet Medical Needs
Jan 2025
Add Mountainfield Venture Partners to your investor list
Sign up free to save investors, see partner contacts, and track your raise.
Sign up